Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-30
2005-08-30
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S340000
Reexamination Certificate
active
06936621
ABSTRACT:
The invention relates to the use of compounds of formulafor the preparation of medicines designed for the treatment of neuronal and cerebral disorders.The invention also relates to the compounds of formula:a process for their preparation and the pharmaceutical compositions containing them.
REFERENCES:
patent: 5229389 (1993-07-01), Coude et al.
patent: 5270320 (1993-12-01), Coude et al.
patent: 5512584 (1996-04-01), Steiner et al.
patent: 91/08200 (1991-06-01), None
Schuster et al., Journal of Medicinal Chemistry, vol. 36, No. 24, pp. 3923-3929, (1993).
Baroni Marco
Cardamone Rosanna
Fournier Jacqueline
Guzzi Umberto
Ielmini Alessandra
Gupta Balaram
Morris Patricia L.
Sanofi-Aventis
LandOfFree
Use of benzoylalkyl-1,2,3,6-tetrahydropyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of benzoylalkyl-1,2,3,6-tetrahydropyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of benzoylalkyl-1,2,3,6-tetrahydropyridines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3484048